Melanotransferrin induces human melanoma SK-Mel-28 cell invasion in vivo

Yanick Bertrand1, Michel Demeule, Jonathan Michaud-Levesque

  • 1Laboratoire de Médecine Moléculaire, Service d'Hémato-Oncologie-Hôpital Ste-Justine/BIomed-Université du Québec à Montréal, Montréal, Que., Canada H3C 3P8.

Insights

Melanotransferrin (MTf) promotes melanoma progression. Silencing MTf in melanoma cells significantly reduced plasmin activity, migration, and invasion in both in vitro and in vivo models.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Melanotransferrin (MTf) is a glycoprotein highly expressed in melanomas.
  • MTf expression correlates with tumor vascularization and progression, suggesting a proinvasive role.

Purpose of the Study:

  • To investigate the role of MTf in melanoma invasiveness.
  • To determine if MTf silencing affects plasmin activity, cell migration, and metastasis.

Main Methods:

  • Human melanoma SK-MEL-28 cells were treated with small interfering RNA (siRNA) to silence MTf expression.
  • In vitro assays assessed cell surface plasminogen activation and cell migration.
  • An in vivo nude mice metastasis model was used to evaluate invasive potential.

Main Results:

  • MTf knockdown inhibited cell surface plasminogen activation to plasmin by 58%.
  • Decreased MTf expression reduced melanoma cell migration.
  • In vivo, MTf-silenced cells showed a fivefold reduction in lung invasion.

Conclusions:

  • MTf overexpression contributes to melanoma progression.
  • MTf promotes tumor invasion by stimulating plasmin generation, cell migration, and metastasis.

Related Concept Videos